Atlas Trials

Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease

Clinical trial NCT00169923 · WITHDRAWN

Trial details

NCT number
NCT00169923
Sponsor
Leiden University Medical Center
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseaseInflammation
Start date
2007-04-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.